|
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study |
|
|
|
Titel: |
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study |
Auteur: |
Santoni, Matteo Myint, Zin W. Büttner, Thomas Takeshita, Hideki Okada, Yohei Lam, Elaine T. Gilbert, Danielle Küronya, Zsófia Tural, Deniz Pichler, Renate Grande, Enrique Crabb, Simon J. Kemp, Robert Massari, Francesco Scagliarini, Sarah Iacovelli, Roberto Vau, Nuno Basso, Umberto Maruzzo, Marco Molina-Cerrillo, Javier Galli, Luca Bamias, Aristotelis De Giorgi, Ugo Zucali, Paolo Andrea Rizzo, Mimma Seront, Emmanuel Popovic, Lazar Caffo, Orazio Buti, Sebastiano Kanesvaran, Ravindran Kopecky, Jindrich Kucharz, Jakub Zeppellini, Annalisa Fiala, Ondřej Landmesser, Johannes Ansari, Jawaher Giannatempo, Patrizia Rizzo, Alessandro Zabalza, Ignacio Ortego Monteiro, Fernando Sabino M. Battelli, Nicola Calabrò, Fabio Porta, Camillo |
Verschenen in: |
Cancer, immunology, immunotherapy |
Paginering: |
Jaargang 72 () nr. 9 pagina's 2961-2970 |
Jaar: |
2023-05-29 |
Inhoud: |
|
Uitgever: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|